Dimetane-dc

   
Google
 
Web NewDrugInformation.com

Dimetane-dc


Drug - Dimetane-dc
The trade name of the product as shown on the labeling.

Dosage - SYRUP; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Brompheniramine Maleate; Codeine Phosphate; Phenylpropanolamine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 2MG/5ML;10MG/5ML;12.5MG/5ML
The potency of the active ingredient(s), Brompheniramine Maleate; Codeine Phosphate; Phenylpropanolamine Hydrochloride. May repeat for multiple part products.

Applicant - ROBINS AH
The firm name holding legal responsibility for Dimetane-dc. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011694
The FDA assigned number to Dimetane-dc. Format is nnnnnn.

Product Number - 006
The FDA assigned number to identify Dimetane-dc. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 29, 1984
The date Dimetane-dc was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Dimetane-dc. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Dimetane-dc is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ah Robins Co
The full name of the firm holding legal responsibility for the new application of Dimetane-dc.

Dimetane-dc